In a research note to investors, Stifel Nicolaus Boosted Price Target on Mednax, Inc (NYSE:MD) with a Buy and $91.00 price target.
Shares of Mednax, Inc (NYSE:MD) are trading +0.77% at the time of writing and in the range of 78.30 – 79.91 for the current session.
On a consensus level, sell-side research analysts have a consensus price target of 89.91 on the stock. This is the average of the individual targets from the covering analysts polled by Thomson Reuters First Call. Analysts are projecting that the company will report earnings per share of 1.03 for next quarter. For the current year, research firms are anticipating earnings of 3.69 per share.
On a technical level the stock has a 50 Day Moving Average of 80.80. Based on a recent trade, this puts the equity at -3.09% away from that average. In comparing the stock’s current level to its extended history, the stock is trading -9.05% away from its 52 week high of 86.09 and +57.17% away from the stock’s low point over the past 52 weeks, which was 49.82.
The price to earnings ratio, or the valuation ratio of a company’s current share price compared to its per-share earnings sits at 23.13. This is an important indicator as a higher ratio typically suggests that investors are expecting higher future earnings growth compared to companies in the same industry with lower price to earnings ratios. When calculating in the EPS estimates for the current year from sell-side analysts, the Price to current year EPS stands at 21.45. Investors looking further ahead, will note that the Price to next year’s EPS is 19.05.
Today the stock opened the current trading session at 79.63 and at the time of writing the last Bid was at 78.30. In the current session the stock reached as high as 79.91 and dipped down to 78.30. Mednax, Inc. Common Stock, a NYQ listed company, has a current market cap of 7.24B and on average over the past 3 months has seen 663458 shares trade hands on a daily basis.